Khint E K, Bokhman Ia V, Vel'gre R Iu, Revazishvili T V
Vopr Onkol. 1975;21(8):83-7.
Of total number of patients with cervical cancer (12687) since 1962 to 1972 155 (1.2%) were subjected to therapy for cancer of the cervical stump. In 5 of 155 patients (3.2%) preinvasive cancer of the cervical stump was observed. Preliminary supravaginal hysterectomy was performed for benign pathological processes of the female genitalia, hysterectomy was performed for benign pathological processes of the female genitalia, including 86.5%--for uterine fibromyoma. Recently, a prolonged interval (10 years and longer) elapsed since supravaginal hysterectomy is typical for patients in whom cancer of the cervical stump develop. Hence, a careful follow-up of patients during the life period after supravaginal hysterectomy seems to be hardly feasible as it should be recommended, and it could not be an adequate prophylactic measure without using a cytologic assay. An idea of the rationality of using extirpation in climacteric and menopausal patients with fibromyoma is being substantiated.
自1962年至1972年,在总共12687例宫颈癌患者中,有155例(1.2%)接受了宫颈残端癌的治疗。在155例患者中有5例(3.2%)观察到宫颈残端原位癌。因女性生殖器良性病变进行了初步经阴道子宫切除术,因女性生殖器良性病变进行了子宫切除术,其中86.5%是因子宫肌瘤。最近,经阴道子宫切除术后间隔时间延长(10年及更长时间)是宫颈残端癌患者的典型情况。因此,按照建议在经阴道子宫切除术后的生存期对患者进行仔细随访似乎很难做到,而且不使用细胞学检测就不可能是一种充分的预防措施。正在证实对患有子宫肌瘤的更年期和绝经后患者采用切除术的合理性。